Amy Beumer, Ph.D.

2.5K posts

Amy Beumer, Ph.D.

@amybeumer

MBC advocate, microbiologist, educator, nature lover, gardener, reader, and feminist. She/her/hers.

Katılım Mayıs 2014

505 Takip Edilen615 Takipçiler

Amy Beumer, Ph.D.@amybeumer·19 Ara

Recovering from #SABCS25 (and working on a report back) and want to say thank you to all the researchers who presented and/or had any part in presented work. It's truly amazing the dedication and hard work by so many people. Appreciate you all!

English

1.2K

Amy Beumer, Ph.D.@amybeumer·19 Ara

@JaniceTNBCmets Love the realism! Very cool

English

Janice Cowden@JaniceTNBCmets·19 Ara

@amybeumer - a potential addition for your beautiful spinning science presentations?! 😂

English

Janice Cowden@JaniceTNBCmets·19 Ara

Love a good scientific illustration! #ScienceNerd #bcsm #metastaticbreastcancer

Yakup Ergün@dr_yakupergun

T-DXd: Mechanism of Action — Visualized A few years ago, we were actively looking for professional illustrators to create figures like these. Now, a single-line prompt is often enough to generate high-fidelity, scientifically accurate visuals💥

English

360

Amy Beumer, Ph.D.@amybeumer·13 Ara

If I remember correctly this happened last year as well….disappointing doesn’t quite cover it.

English

199

Amy Beumer, Ph.D. retweetledi

Christine Hodgdon@christeeny513·12 Ara

Patient advocate Samantha Horn opens with a powerful question: “what were you doing in your 20s?” For her, it was chemo. ICYMI, this is a must-watch educational session on breast cancer in young women. #sabcs25 #oncoalert

English

414

Amy Beumer, Ph.D.@amybeumer·12 Ara

@JaniceTNBCmets giving the patient perspective on mTNBC- we don’t just want to live longer we want to live well. Dosing is one way to improve quality of life on toxic ADCs. #SABCS25

English

299

Amy Beumer, Ph.D.@amybeumer·12 Ara

Disappointed in the mass exodus as the patient advocate is coming in to discuss the patient perspective on mTNBC. #SABCS25

English

172

Amy Beumer, Ph.D.@amybeumer·12 Ara

Looking forward to this- join me!!

Christine Hodgdon@christeeny513

Quality of life matters! Join Poster author @amybeumer of the Patient-Centered Dosing Initiative (PCDI @TheRightDose) at poster walkthroughs next week to discuss findings from a large MBC patient survey that highlight the need for more individualized dosing strategies.

English

374

Amy Beumer, Ph.D.@amybeumer·11 Ara

@DrSGraff @SABCSSanAntonio @OncoAlert Thank you!

English

Stephanie Graff, MD, FACP, FASCO@DrSGraff·10 Ara

Patient advocate @amybeumer gives another master class on the patient experience #SABCS25 @SABCSSanAntonio @OncoAlert

Stephanie Graff, MD, FACP, FASCO tweet media

Stephanie Graff, MD, FACP, FASCO@DrSGraff

TDXd QoL from DB11 “How bothered are you by effects of cancer treatment” Color scale: 🔴Very much 🍊Quite a bit 🌕Somewhat 🟢A little bit 🫑Not at all #SABCS25

English

2.2K

Amy Beumer, Ph.D. retweetledi

Nicole Casasanta, MD@ncasasanta·11 Ara

📢 Amazing talks by @amybeumer & @maryam_lustberg on PROs in cancer trials 🤝partnership w/ patient advocates in design 🔹consider type & timing of PRO 🔹research needed in effective & tolerable dosing strategies 🔹real world data provides key insight @GRASPtweets @the_rightdose

English

679

Amy Beumer, Ph.D.@amybeumer·11 Ara

@esrajustesra @AMJohnston1315 @stage4kelly Happy to report back (took a lot of notes)- might need a couple days. The v. short is lots of work looking at resistance mechanisms in CDK 4/6i and ADCs and how they might be targeted or at least detected to predict resistance.

English

Esra@esrajustesra·10 Ara

@amybeumer @AMJohnston1315 @stage4kelly Wonderful! Looking forward to hear about it from you. Thanks Amy!💜

English

Esra@esrajustesra·9 Ara

Can any of the patient advocates at #SABCS25 give more info on this ? @AMJohnston1315 @stage4kelly

Dana-Farber’s Breast Oncology Center@DFCI_BreastOnc

Join Dr. Ana Garrido-Castro at #SABCS25 for Poster Spotlight 3 on molecular characterization of resistance to #AntibodyDrugConjugates in #MetastaticBreastCancer: A prospective analysis from the AURORA US Network. 🗓️ Wed, Dec. 10 ⏰ 7:00 - 8:30 am CST (8 - 9:30 am EST) 📍 302 ABC #BreastCancer #MBC #CDKinhibitors #ADCs

English

243

Amy Beumer, Ph.D.@amybeumer·11 Ara

@maryam_lustberg @OncoAlert Thank you for including us - as always you are a champion for patients and advocates <3

English

Maryam Lustberg MD, MPH, FASCO@maryam_lustberg·11 Ara

Amazing presentation on importance of right dosing and measuring all that matters in cancer trials and beyond @amybeumer @OncoAlert

Yale Cancer Center@YaleCancer

Powerful message from @amybeumer at #SABCS25: It’s time to “fix the toxic friendship” and design dosing with patients—balancing side effects, quality of life, and longevity. @the_rightdose @YaleBreast @maryam_lustberg @SABCSSanAntonio

English

860

Amy Beumer, Ph.D.@amybeumer·10 Ara

@stage4kelly Get some rest and pace yourself :-) See you soon!

English

Dr. Kelly Shanahan@stage4kelly·10 Ara

@amybeumer I just hit the afternoon wall and can no longer keep up, so I’ll be watching the rest of this (Dr Goel’s presentation, which is also excellent ) tonight and sharing later. #SABCS25 #BrainIsFriedAndItsOnlyDayOne

English

Dr. Kelly Shanahan@stage4kelly·9 Ara

With the majority of people with MBC having HR+ disease, and most of them given a CDK4/6 inhibitor in the first line, we need to know what to do when there is (almost) inevitably progression #SABCS25 #bcsm

English

380

Amy Beumer, Ph.D. retweetledi

Dr. Kelly Shanahan@stage4kelly·9 Ara

Grateful to @christeeny513 for sharing her story - and how her concerns of a lump were initially dismissed with something far too many hear: “you’re too young for breast cancer”. No one is too young and everyone deserves to have their concerns addressed. #SABCS25 #bcsm

English

783

Amy Beumer, Ph.D. retweetledi

Dr. Kelly Shanahan@stage4kelly·9 Ara

This exactly what we need - guidance to mitigate the side effects from our treatments. Many of us start antihistamines a few days before beginning capi and never have to deal with the rash. And for those super sensitive to loperamide 🙋‍♀️off label crofelemer can be a game changer.

Neil Iyengar, MD@Neil_Iyengar

As we kick off #SABCS25, excited to share our new recommendations paper for capivasertib in HR+ MBC: 10 practical recommendations to optimize treatment and patient experience. nature.com/articles/s4152… @HeatherMoore16 @ErikaHamilton9 @jhaveri_komal @hoperugo @WinshipAtEmory

English

767

Amy Beumer, Ph.D.@amybeumer·10 Ara

@Delta couldn’t get me to #SABCS25 yesterday and today another delay meant (coming up on) ten hours of travel. So sad to be missing friends, science and great talks. Hope to see you tonight at one of my favorite events the @GRASPtweets reception!

English

Amy Beumer, Ph.D.@amybeumer·10 Ara

@stage4kelly So mad I’m missing all this and thank you so much for sharing! Can’t wait to go back and watch the video.

English

Dr. Kelly Shanahan@stage4kelly·9 Ara

There are many agents targeting the PI3K/AKT pathway, with 3 giving updates during #SABCS25

English

155

Amy Beumer, Ph.D.@amybeumer·5 Ara

@AMJohnston1315 @itsnot_pink @GRASPtweets Me too!

English

Abigail Johnston@AMJohnston1315·5 Ara

@itsnot_pink @GRASPtweets One of my favorite parts of SABCS!

English

Julia Maués@itsnot_pink·4 Ara

Attending #SABCS25? Join the @GRASPtweets reception, one of the few opportunities for scientists, clinicians & patient advocates to connect. It's where so many collaborations are born to bring the patient experience to research! Register here: graspcancer.org/event/sabcs25-…